Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICG Injection Protocols for Biliary Visualization
NCT05926856Phase 3Completed
- Sponsor
- Southern Medical University Zhujiang Hospital
- Start
- Aug 2023
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of indocyanine green in Extrahepatic bile duct injury (EHBDI), sponsored by Southern Medical University Zhujiang Hospital. Started Aug 2023; status: completed.
02
Drugs
indocyanine green
03
Conditions
Extrahepatic bile duct injury (EHBDI)
Beyond the preview
Go deeper on NCT05926856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05926856.